menu Search
Monlastik

Monlastik

montelukast

Manufacturer:

Flamingo Pharma

Distributor:

Trumed
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Montelukast
Indications/Uses
Chronic treatment of asthma in adults & ped patients ≥12 mth. Symptomatic relief of allergic rhinitis (seasonal allergic rhinitis in adults & ped patients ≥2 yr, & perennial allergic rhinitis in adults & ped patients ≥6 mth).
Click to view Monlastik detailed prescribing information
Dosage/Direction for Use
Asthma & allergic rhinitis 1 tab daily in the evening. Prevention of exercise-induced bronchoconstriction (EIB) Patient ≥15 yr 1 tab daily as single dose at least 2 hr before exercise for prevention of EIB. Additional dose should not be taken w/in 24 hr of a previous dose. Patient already taking 1 tab daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB.
Click to view Monlastik detailed prescribing information
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Click to view Monlastik detailed prescribing information
Special Precautions
Not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Montelukast therapy can be continued during acute asthma exacerbations. Should not be abruptly substituted for inhaled or oral corticosteroids. Not to be used as monotherapy for the therapy & management of EIB. Patients w/ known aspirin sensitivity should continue avoidance of aspirin or NSAIDs during treatment. Be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, &/or neuropathy.
Click to view Monlastik detailed prescribing information
Adverse Reactions
Dyspepsia, abdominal pain, rash, dizziness, headache, fatigue, fever, trauma, cough, nasal congestion.
Click to view Monlastik detailed prescribing information
Drug Interactions
Caution w/ potent CYP3A4 inducers (eg, phenytoin, phenobarb, or rifampicin). Reports of peripheral oedema w/ prednisone. Reduced peak serum conc & AUC w/ phenobarb.
Click to view Monlastik detailed prescribing information
Storage
View Monlastik storage conditions for details to ensure optimal shelf-life.
Description
View Monlastik description for details of the chemical structure and excipients (inactive components).
Action
View Monlastik mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Regulatory Classification
Rx
Presentation/Packing
Form
Monlastik FC tab 10 mg
Packing/Price
100's